PUMA BIOTECHNOLOGY INC's ticker is PBYI and the CUSIP is 74587V107. A total of 176 filers reported holding PUMA BIOTECHNOLOGY INC in Q2 2018. The put-call ratio across all filers is 0.99 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $1,520,000 | +90.7% | 39,179 | 0.0% | 0.02% | +58.3% |
| Q4 2018 | $797,000 | -68.4% | 39,179 | -28.8% | 0.01% | -62.5% |
| Q3 2018 | $2,524,000 | -33.9% | 55,048 | -14.8% | 0.03% | -39.6% |
| Q2 2018 | $3,820,000 | +135.1% | 64,585 | +170.4% | 0.05% | +112.0% |
| Q1 2018 | $1,625,000 | -24.8% | 23,882 | +9.3% | 0.02% | -19.4% |
| Q4 2017 | $2,160,000 | -24.2% | 21,856 | -8.1% | 0.03% | -22.5% |
| Q3 2017 | $2,849,000 | -18.2% | 23,792 | -40.3% | 0.04% | -24.5% |
| Q2 2017 | $3,481,000 | +180.5% | 39,834 | +19.4% | 0.05% | +152.4% |
| Q1 2017 | $1,241,000 | +34.7% | 33,369 | +11.2% | 0.02% | +16.7% |
| Q4 2016 | $921,000 | -54.2% | 30,000 | 0.0% | 0.02% | -48.6% |
| Q3 2016 | $2,012,000 | – | 30,000 | – | 0.04% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EcoR1 Capital, LLC | 2,536,156 | $21,405,000 | 2.24% |
| Palo Alto Investors LP | 1,396,163 | $11,784,000 | 0.99% |
| Camber Capital Management LP | 1,950,000 | $16,458,000 | 0.98% |
| TANG CAPITAL MANAGEMENT LLC | 800,000 | $6,752,000 | 0.95% |
| Capital Impact Advisors, LLC | 147,303 | $1,243,000 | 0.52% |
| Sofinnova Investments, Inc. | 638,026 | $5,385,000 | 0.50% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 963,212 | $8,130,000 | 0.26% |
| RICE HALL JAMES & ASSOCIATES, LLC | 466,482 | $3,937,000 | 0.22% |
| PDT Partners, LLC | 204,238 | $1,724,000 | 0.14% |
| Eversept Partners, LP | 58,251 | $491,638 | 0.12% |